Hepatocellular carcinoma Trials in Oviedo, Spain
Conditions / Hepatocellular carcinoma / Oviedo, Spain
Hepatocellular carcinoma is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04194775 | A Study of Nofazinlimab (CS1003) in Subjects With Advanced Hepatocellular Carcinoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03867084 | Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937) | COMPLETED | — |
| NCT03380130 | A Study of the Safety and Antitumoral Efficacy of Nivolumab After SIRT for the Treatment of Patients With HCC | COMPLETED | PHASE2 |
| NCT03170960 | Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT03298451 | Study of Durvalumab and Tremelimumab as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT04316182 | Cabozantinib in Patients With Hepatocellular Carcinoma (ACTION) | COMPLETED | PHASE2 |
| NCT01755767 | Study of Tivantinib in Subjects With Inoperable Hepatocellular Carcinoma (HCC) Who Have Been Treated With One Prior Therapy | COMPLETED | PHASE3 |
| NCT05063565 | TheraSphere With Durvalumab and Tremelimumab for HCC | ACTIVE_NOT_RECRUITING | — |
| NCT04170556 | Regorafenib Followed by Nivolumab in Patients With Hepatocellular Carcinoma (GOING) | COMPLETED | PHASE1/PHASE2 |
| NCT05904886 | A Study Evaluating Atezolizumab and Bevacizumab, With or Without Tiragolumab, in Participants With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (HCC) (IMbrave152) | ACTIVE_NOT_RECRUITING | PHASE3 |